​

Funding Round

Series C - ENYO Pharma

Series C - ENYO Pharma

Investment Firm

Overview

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

Announced Date

Jan 03, 2024

Funding Type

Series C

Highlights

Location

Europe

Social

Investor Lead

OrbiMed

OrbiMed

OrbiMed is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Morningside Venture Investments

Morningside Venture Investments

Morningside Venture Investments is a private_equity and venture firm.

Participant Investors

5

Investor Name
Participant InvestorBpifrance InnoBio
Participant InvestorBpifrance Large Venture
Participant InvestorMorningside Venture Investments
Participant InvestorOrbiMed
Participant InvestorAndera Partners

Round Details and Background

ENYO Pharma raised $42610610 on 2024-01-03 in Series C

ENYO Pharma is a biopharmaceutical company based in Lyon, France.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 04, 2018
Series B - ENYO Pharma
7-46.8M
Jan 03, 2024
Series C - ENYO Pharma
5-42.6M
Dec 06, 2016
Grant - ENYO Pharma
1-2.7M
Jan 03, 2016
Series A - ENYO Pharma
1-23.9M

Recent Activity

There is no recent news or activity for this profile.